Expansion of clinical and variant spectrum of EEF2 ‐related neurodevelopmental disorder: Report of two additional cases
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63230 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Rose Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Children's Hospital of Philadelphia, Pennsylvania, Pennsylvania, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Neurodevelopmental Disorders, Language Development Disorders, Intellectual Disability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Eukaryotic translation elongation factor 2 (eEF2), encoded by the gene EEF2 , is an essential factor involved in the elongation phase of protein translation. A specific heterozygous missense variant (p.P596H) in EEF2 was originally identified in association with autosomal dominant adult‐onset spinocerebellar ataxia‐26 (SCA26). More recently, additional heterozygous missense variants in this gene have been described to cause a novel, childhood‐onset neurodevelopmental disorder with benign external hydrocephalus. Herein, we report two unrelated individuals with a similar gene‐disease correlation to support this latter observation. Patient 1 is a 7‐year‐old male with a previously reported, de novo missense variant (p.V28M) who has motor and speech delay, autism spectrum disorder, failure to thrive with relative macrocephaly, unilateral microphthalmia with coloboma and eczema. Patient 2 is a 4‐year‐old female with a novel de novo nonsense variant (p.Q145X) with motor and speech delay, hypotonia, macrocephaly with benign ventricular enlargement, and keratosis pilaris. These additional cases help to further expand the genotypic and phenotypic spectrum of this newly described EEF2‐ related neurodevelopmental syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Genetics, Children's Hospital of Philadelphia, Pennsylvania, Pennsylvania, USA.
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, University of California San Diego; Division of Dysmorphology/Genetics, Rady Children's Hospital San Diego, San Diego, California, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Lynne M Bird
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Guo, R., Rippert, A. L., Cook, E. B., Alves, C. A. P., Bird, L. M., & Izumi, K. (2023). Expansion of clinical and variant spectrum of EEF2 ‐related neurodevelopmental disorder: Report of two additional cases. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63230
Vancouver
Guo R, Rippert AL, Cook EB, Alves CAP, Bird LM, Izumi K. Expansion of clinical and variant spectrum of EEF2 ‐related neurodevelopmental disorder: Report of two additional cases. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63230
BibTeX
@article{Guo2023,
author = {Guo, Rose and Rippert, Alyssa L and Cook, Edward B and Alves, Cesar Augusto P and Bird, Lynne M and Izumi, Kosuke},
title = {Expansion of clinical and variant spectrum of EEF2 ‐related neurodevelopmental disorder: Report of two additional cases},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63230}
}
EUVIMED